Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas.
Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas.
复制标题
布鲁萨醇抑制肿瘤生长并提高卡麦角林抗垂体腺瘤的功效
DOI:
10.1155/2021/6696015
复制
发表时间:
2021
影响因子:
--
通讯作者:
Su Z
中科院分区:
文献类型:
--
作者:
Wu Z;Xu Y;Xu J;Lu J;Cai L;Li Q;Wang C;Su Z
Cabergoline (CAB) is the first choice for treatment of prolactinoma and the most common subtype of pituitary adenoma. However, drug resistance and lack of effectiveness in other pituitary tumor types remain clinical challenges to this treatment. Brusatol (BT) is known to inhibit cell growth and promote apoptosis in a variety of cancer cells. In our present studies, we investigate the effects of BT on pituitary tumor cell proliferation in vitro and in vivo. BT treatment resulted in an increase in Annexin V-expressing cells and promoted the expression of apoptosis-related proteins in rat and human pituitary tumor cells. Investigation of the mechanism underlying this effect revealed that BT increased the production of reactive oxygen species (ROS) and inhibited the phosphorylation of 4EBP1 and S6K1. Furthermore, treatment with a combination of BT and CAB resulted in greater antitumor effects than either treatment alone in nude mice and pituitary tumor cells. Collectively, our results suggest that the BT-induced ROS accumulation and inhibition of mTORC1 signaling pathway leads to inhibition of tumor growth. Combined use of CAB and BT may increase the clinical effectiveness of treatment for human pituitary adenomas.
登录
查看更多内容
影响因子:
5.8
作者:
Lin, Shao Jian;Wu, Ze Rui;Wu, Zhe Bao
通讯作者:
Wu, Zhe Bao
影响因子:
4.6
作者:
Harder B;Tian W;La Clair JJ;Tan AC;Ooi A;Chapman E;Zhang DD
通讯作者:
Zhang DD
影响因子:
3
作者:
Guo, Songbin;Zhang, Jinling;Zhang, Zhenfeng
通讯作者:
Zhang, Zhenfeng
影响因子:
7.5
作者:
Cai, Sabrina J.;Liu, Yang;Yang, Chunzhang
通讯作者:
Yang, Chunzhang
影响因子:
5.5
作者:
Lee, Jong Hyun;Rangappa, Shobith;Ahn, Kwang Seok
通讯作者:
Ahn, Kwang Seok